The iFuse is a titanium implant coated with a porous plasma spray acting as an interference surface fit to decrease implant motion. SI-BONE received original clearance in November 2008 from the FDA to market iFuse and an updated clearance in April 2011 for additional conditions including sacroiliac joint disruptions and degenerative sacroiliitis. The CE mark for European commercialization was obtained in November 2010.
More Articles on Orthopedic Devices:
20 Spine Devices Receive FDA 510(k) Clearance in June
Maxx Medical’s Freedom Total Knee System Now Available in China
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
